Epigenetic silencing of miR-338 facilitates glioblastoma progression by de-repressing the pyruvate kinase M2-β-catenin axis

Bo Han, Xiangqi Meng, Hui Chen, Lingchao Chen, Xing Liu, Hongjun Wang, Daming Liu, Fei Gao, Lin Lin, Jianguang Ming,

Aging · 2017 · 22 citations · 31 references

DOIFull text

Open access

Concepts

Abstract

, which ultimately prevented binding of PKM2 to β-catenin and reduced T-cell factor/lymphoid enhancer factor reporter gene transcriptional activity. MiR-338 also inhibited PKM2 expression, attenuated glioma growth and prolonged survival in an animal model. These results confirm that miR-338, a tumor suppressor, suppresses the PKM2/β-catenin axis and is downregulated in glioblastoma. This provides a theoretical basis for glioma-targeting therapy.

References

31